CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 43 filers reported holding CYCLERION THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $35,055 | -33.9% | 80,792 | 0.0% | 0.00% | – |
Q4 2022 | $53,016 | -23.2% | 80,792 | 0.0% | 0.00% | – |
Q3 2022 | $69,000 | +56.8% | 80,792 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | -51.1% | 80,792 | 0.0% | 0.00% | – |
Q1 2022 | $90,000 | -35.3% | 80,792 | 0.0% | 0.00% | – |
Q4 2021 | $139,000 | -36.8% | 80,792 | +12.4% | 0.00% | – |
Q3 2021 | $220,000 | -12.7% | 71,880 | +11.2% | 0.00% | – |
Q2 2021 | $252,000 | -62.2% | 64,616 | -73.0% | 0.00% | – |
Q1 2021 | $667,000 | -15.2% | 239,015 | -7.0% | 0.00% | – |
Q4 2020 | $787,000 | -51.4% | 257,044 | -3.4% | 0.00% | – |
Q3 2020 | $1,618,000 | +11.1% | 266,093 | +8.0% | 0.00% | – |
Q2 2020 | $1,456,000 | +100.8% | 246,442 | -10.0% | 0.00% | – |
Q1 2020 | $725,000 | -7.1% | 273,741 | -4.6% | 0.00% | – |
Q4 2019 | $780,000 | -77.3% | 286,960 | +1.3% | 0.00% | -100.0% |
Q3 2019 | $3,433,000 | +57.8% | 283,294 | +49.0% | 0.00% | 0.0% |
Q2 2019 | $2,176,000 | +1218.8% | 190,151 | +1681.4% | 0.00% | – |
Q1 2019 | $165,000 | – | 10,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 7,157,601 | $6,156,000 | 0.40% |
MFN Partners Management, LP | 3,389,215 | $2,915,000 | 0.13% |
Diametric Capital, LP | 243,711 | $210,000 | 0.11% |
Artal Group S.A. | 2,779,122 | $2,391,000 | 0.10% |
Intrinsic Value Partners, LLC | 48,315 | $42,000 | 0.06% |
TRUSTCORE FINANCIAL SERVICES, LLC | 292,645 | $252,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $99,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 92,541 | $80,000 | 0.00% |
COLONY GROUP LLC | 102,884 | $88,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 231,952 | $198,000 | 0.00% |